CONSUN PHARMAC.GR.HD -,10 financial statements, including revenue, expenses, profit, and loss

The total revenue of C1P for the last semiannual is 184.27 M EUR, and it's 24.42% higher compared to the previous semiannual. The net income of H2 23 is 54.72 M EUR.